gs-5718
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2021 (NCT04809623)
Timeline
Indications
Mechanism of action
IRAK4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05629208 | Phase 2 | Mar 31, 2023 | Gilead Sciences |
| NCT05165771 | Phase 2 | Dec 31, 2021 | Gilead Sciences |
| NCT04809623 | Phase 1 | Sep 1, 2021 | Gilead Sciences |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gilead Sciences | For profit | 3 | 3 | 2 | 2021 |
1 organizations
Page 1 / 1